SCHEMBL4352978

SCHEMBL4352978

COc1ccc(Sc2ccccc2CNc2cccc(Cl)c2O)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.58
KMT2A Q03164 2/20 0.58
MEN1 O00255 1/20 0.58
MMP2 P08253 5/20 0.54
MMP9 P14780 5/20 0.54
MMP12 P39900 5/20 0.54
MMP14 P50281 1/20 0.54
KDM4E B2RXH2 2/20 0.45
LMNA P02545 2/20 0.44
GAA P10253 2/20 0.44
PTGIR P43119 1/20 0.40
ALDH1A1 P00352 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CYP3A4 P08684 1/20 0.39
MAPT P10636 1/20 0.39
CYP2C9 P11712 1/20 0.39
HPGD P15428 1/20 0.39
CYP2C19 P33261 1/20 0.39
HTT P42858 1/20 0.39
SLC6A4 P31645 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4345485 0.88 KMT2A (0.55) POLBKMT2AMEN1MMP2MMP9
SCHEMBL4354753 0.87 MEN1 (0.60) POLBKMT2AMEN1MMP2MMP9
SCHEMBL4345359 0.87 SLC6A4 (0.40) POLBKMT2AMEN1MMP2MMP9
SCHEMBL4346907 0.87 SLC6A4 (0.48) POLBKMT2AMEN1KDM4ELMNA
SCHEMBL4351156 0.86 SMN1; SMN2 (0.43) KMT2AMEN1LMNAGAAALDH1A1
SCHEMBL4349903 0.86 MEN1 (0.58) POLBKMT2AMEN1MMP2MMP9
SCHEMBL4352963 0.84 KMT2A (0.56) POLBKMT2AMEN1MMP2MMP9
SCHEMBL4350040 0.84 KMT2A (0.58) POLBKMT2AMEN1MMP2MMP9
SCHEMBL4355817 0.84 KMT2A (0.53) POLBKMT2AMEN1MMP2MMP9
SCHEMBL4354379 0.83 MMP2 (0.57) POLBKMT2AMEN1MMP2MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF JERINI AG (DE) 2011-03-17 US claimed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP claimed
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors JERINI AG (DE) 2007-03-08 US claimed
CN-1701061-A Novel compounds for inhibiting rotamase enzymes and uses thereof JERINI AG (DE) 2005-11-23 CN claimed
EP-1539683-A2 PHENOL DERIVATIVES AND THEIR USE AS ROTAMASE INHIBITORS Jerini AG (DE) 2005-06-15 EP claimed
WO-2004030664-A2 NEW COMPOUNDS FOR THE INHIBITION OF UNDESIRED CELL PROLIFERATION AND USE THEREOF JERINI AG (DE) 2004-04-15 WO claimed
WO-2004026815-A2 PHENOL DERIVATIVES AND THEIR USE AS ROTAMASE INHIBITORS JERINI AG (DE) 2004-04-01 WO claimed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF NR1I3, NR1D1, NR1D2 POLB 3571/4885KMT2A 2096/4885MEN1 2168/4885
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors NR1I3, NR1D1, NR1D2 POLB 2402/4885KMT2A 1254/4885MEN1 3901/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.